- Jan 11, 2012

Experimental neuroblastoma drug shows promise in the lab

Laboratory studies in the US have confirmed the promise of an experimental drug against a particularly aggressive form of neuroblastoma, the most common non-blood cancer in children.

Prediabetes in Childhood Cancer Survivors Ups Cardiovascular, CKD Risks

Besponsa ‘More Effective’ at Driving Remission for Pediatric B-ALL

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

Researchers turn back the clock on cancer cells to offer new treatment paradigm

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Predicting Infection Risk in Childhood Cancer

Researchers find genetic variant contributing to disparities in childhood leukemia risk

Chemotherapy cured my cancer. Years later it likely gave me heart disease.

How Cancer Can Shape Young Patients’ Sense of Identity

Recent Posts

Experimental neuroblastoma drug shows promise in the lab

Archive

Search By Tags